Ternary model structural complex of C5a, C5aR2, and β-arrestin1

References

• Amadei, A., Linssen, A. B., & Berendsen, H. J. (1993). Essential dynamics of proteins. Proteins, 17(4), 412–425. https://doi.org/10.1002/prot.340170408
   PubMed Web of Science ®Google Scholar
• Aydin, Y., Bottke, T., Lam, J. H., Ernicke, S., Fortmann, A., Tretbar, M., Zarzycka, B., Gurevich, V. V., Katritch, V., & Coin, I. (2023). Structural details of a class B GPCR-arrestin complex revealed by genetically encoded crosslinkers in living cells. Nature Communications, 14(1), 1151. https://doi.org/10.1038/s41467-023-36797-2
   PubMed Web of Science ®Google Scholar
• Bamberg, C. E., Mackay, C. R., Lee, H., Zahra, D., Jackson, J., Lim, Y. S., Whitfeld, P. L., Craig, S., Corsini, E., Lu, B., Gerard, C., & Gerard, N. P. (2010). The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction. The Journal of Biological Chemistry, 285(10), 7633–7644. https://doi.org/10.1074/jbc.M109.092106
   PubMed Web of Science ®Google Scholar
• Bos, J. L., Rehmann, H., & Wittinghofer, A. (2007). GEFs and GAPs: Critical elements in the control of small G proteins. Cell, 129(5), 865–877. https://doi.org/10.1016/j.cell.2007.05.018
   PubMed Web of Science ®Google Scholar
• Bous, J., Fouillen, A., Orcel, H., Trapani, S., Cong, X., Fontanel, S., Saint-Paul, J., Lai-Kee-Him, J., Urbach, S., Sibille, N., Sounier, R., Granier, S., Mouillac, B., & Bron, P. (2022). Structure of the vasopressin hormone-V2 receptor-beta-arrestin1 ternary complex. Science Advances, 8(35), eabo7761. https://doi.org/10.1126/sciadv.abo7761
   PubMed Web of Science ®Google Scholar
• Cao, C., Barros-Alvarez, X., Zhang, S., Kim, K., Damgen, M. A., Panova, O., Suomivuori, C. M., Fay, J. F., Zhong, X., Krumm, B. E., Gumpper, R. H., Seven, A. B., Robertson, M. J., Krogan, N. J., Huttenhain, R., Nichols, D. E., Dror, R. O., Skiniotis, G., & Roth, B. L. (2022). Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD. Neuron, 110(19), 3154–3167.e7. https://doi.org/10.1016/j.neuron.2022.08.006
   PubMed Web of Science ®Google Scholar
• Chen, Q., Iverson, T. M., & Gurevich, V. V. (2018). Structural basis of arrestin-dependent signal transduction. Trends in Biochemical Sciences, 43(6), 412–423. https://doi.org/10.1016/j.tibs.2018.03.005
   PubMed Web of Science ®Google Scholar
• Consortium. (2022). UniProt: The universal protein knowledgebase in 2023. Nucleic Acids Research, 51(D1), D523–D531. https://doi.org/10.1093/nar/gkac1052
   Web of Science ®Google Scholar
• Croker, D. E., Halai, R., Kaeslin, G., Wende, E., Fehlhaber, B., Klos, A., Monk, P. N., & Cooper, M. A. (2014). C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and beta-arrestin recruitment. Immunology and Cell Biology, 92(7), 631–639. https://doi.org/10.1038/icb.2014.32
   PubMed Web of Science ®Google Scholar
• Das, A., Behera, L. M., & Rana, S. (2021). Interaction of human C5a with the major peptide fragments of C5aR1: Direct evidence in support of “two-site” binding paradigm. ACS Omega, 6(35), 22876–22887. https://doi.org/10.1021/acsomega.1c03400
   PubMed Web of Science ®Google Scholar
• Das, A., Ghosh, M., Gupta, P. K., & Rana, S. (2023). Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2. Journal of Cellular Biochemistry, 124(2), 266–281. https://doi.org/10.1002/jcb.30360
   PubMed Web of Science ®Google Scholar
• Das, A., Gupta, P. K., & Rana, S. (2022). C5aR2 receptor: The genomic twin of the flamboyant C5aR1. Journal of Cellular Biochemistry, 123(11), 1841–1856. https://doi.org/10.1002/jcb.30320
   PubMed Web of Science ®Google Scholar
• Das, A., & Rana, S. (2021). The role of human C5a as a non-genomic target in corticosteroid therapy for management of severe COVID-19. Computational Biology and Chemistry, 92, 107482. https://doi.org/10.1016/j.compbiolchem.2021.107482
   PubMed Web of Science ®Google Scholar
• DeWire, S. M., Ahn, S., Lefkowitz, R. J., & Shenoy, S. K. (2007). Beta-arrestins and cell signaling. Annual Review of Physiology, 69, 483–510. https://doi.org/10.1146/annurev.physiol.69.022405.154749
   PubMed Web of Science ®Google Scholar
• Eichel, K., Jullié, D., Barsi-Rhyne, B., Latorraca, N. R., Masureel, M., Sibarita, J.-B., Dror, R. O., & von Zastrow, M. (2018). Catalytic activation of β-arrestin by GPCRs. Nature, 557(7705), 381–386. https://doi.org/10.1038/s41586-018-0079-1
   PubMed Web of Science ®Google Scholar
• Fernandez, H. N., & Hugli, T. E. (1978). Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a. The Journal of Biological Chemistry, 253(19), 6955–6964. https://doi.org/10.1016/S0021-9258(17)38013-4
   PubMed Web of Science ®Google Scholar
• Freeley, S., Kemper, C., & Le Friec, G. (2016). The “ins and outs” of complement-driven immune responses. Immunological Reviews, 274(1), 16–32. https://doi.org/10.1111/imr.12472
   PubMed Web of Science ®Google Scholar
• Fritze, O., Filipek, S., Kuksa, V., Palczewski, K., Hofmann, K. P., & Ernst, O. P. (2003). Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation. Proceedings of the National Academy of Sciences of the United States of America, 100(5), 2290–2295. https://doi.org/10.1073/pnas.0435715100
   PubMed Web of Science ®Google Scholar
• Gerard, N. P., & Gerard, C. (1991). The chemotactic receptor for human C5a anaphylatoxin. Nature, 349(6310), 614–617. https://doi.org/10.1038/349614a0
   PubMed Web of Science ®Google Scholar
• Ghosh, M., & Rana, S. (2023). The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics. International Immunopharmacology, 118, 110081. https://doi.org/10.1016/j.intimp.2023.110081
   PubMed Web of Science ®Google Scholar
• Goodman, O. B., Jr., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., & Benovic, J. L. (1996). Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature, 383(6599), 447–450. https://doi.org/10.1038/383447a0
   PubMed Web of Science ®Google Scholar
• Grant, B. J., Rodrigues, A. P., ElSawy, K. M., McCammon, J. A., & Caves, L. S. (2006). Bio3d: An R package for the comparative analysis of protein structures. Bioinformatics (Oxford, England), 22(21), 2695–2696. https://doi.org/10.1093/bioinformatics/btl461
   PubMed Web of Science ®Google Scholar
• Granzin, J., Wilden, U., Choe, H. W., Labahn, J., Krafft, B., & Buldt, G. (1998). X-ray crystal structure of arrestin from bovine rod outer segments. Nature, 391(6670), 918–921. https://doi.org/10.1038/36147
   PubMed Web of Science ®Google Scholar
• Gurevich, V. V., & Gurevich, E. V. (2013). Structural determinants of arrestin functions. Progress in Molecular Biology and Translational Science. 118, 57–92. https://doi.org/10.1016/B978-0-12-394440-5.00003-6
   PubMed Web of Science ®Google Scholar
• Gurevich, V. V., Gurevich, E. V., & Uversky, V. N. (2018). Arrestins: Structural disorder creates rich functionality. Protein & Cell, 9(12), 986–1003. https://doi.org/10.1007/s13238-017-0501-8
   PubMed Web of Science ®Google Scholar
• Gurevich, V. V., Song, X., Vishnivetskiy, S. A., & Gurevich, E. V. (2014). Enhanced phosphorylation-independent arrestins and gene therapy. Handbook of Experimental Pharmacology. 219, 133–152. https://doi.org/10.1007/978-3-642-41199-1_7
   PubMedGoogle Scholar
• Han, M., Gurevich, V. V., Vishnivetskiy, S. A., Sigler, P. B., & Schubert, C. (2001). Crystal structure of beta-arrestin at 1.9 A: Possible mechanism of receptor binding and membrane Translocation. Structure (London, England: 1993), 9(9), 869–880. https://doi.org/10.1016/s0969-2126(01)00644-x
   PubMed Web of Science ®Google Scholar
• Hess, B., Kutzner, C., van der Spoel, D., & Lindahl, E. (2008). GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. Journal of Chemical Theory and Computation, 4(3), 435–447. https://doi.org/10.1021/ct700301q
   PubMed Web of Science ®Google Scholar
• Huang, W., Masureel, M., Qu, Q., Janetzko, J., Inoue, A., Kato, H. E., Robertson, M. J., Nguyen, K. C., Glenn, J. S., Skiniotis, G., & Kobilka, B. K. (2020). Structure of the neurotensin receptor 1 in complex with beta-arrestin 1. Nature, 579(7798), 303–308. https://doi.org/10.1038/s41586-020-1953-1
   PubMed Web of Science ®Google Scholar
• Kahsai, A. W., Pani, B., & Lefkowitz, R. J. (2018). GPCR signaling: Conformational activation of arrestins. Cell Research, 28(8), 783–784. https://doi.org/10.1038/s41422-018-0067-x
   PubMed Web of Science ®Google Scholar
• Kandt, C., Ash, W. L., & Tieleman, D. P. (2007). Setting up and running molecular dynamics simulations of membrane proteins. Methods (San Diego, Calif.), 41(4), 475–488. https://doi.org/10.1016/j.ymeth.2006.08.006
   PubMed Web of Science ®Google Scholar
• Kang, D. S., Kern, R. C., Puthenveedu, M. A., von Zastrow, M., Williams, J. C., & Benovic, J. L. (2009). Structure of an arrestin2-clathrin complex reveals a novel clathrin binding domain that modulates receptor trafficking. Journal of Biological Chemistry. 284(43), 29860–29872. https://doi.org/10.1074/jbc.M109.023366
   PubMed Web of Science ®Google Scholar
• Kang, D. S., Tian, X., & Benovic, J. L. (2014). Role of beta-arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking. Current Opinion in Cell Biology, 27, 63–71. https://doi.org/10.1016/j.ceb.2013.11.005
   PubMed Web of Science ®Google Scholar
• Kang, Y., Zhou, X. E., Gao, X., He, Y., Liu, W., Ishchenko, A., Barty, A., White, T. A., Yefanov, O., Han, G. W., Xu, Q., de Waal, P. W., Ke, J., Tan, M. H., Zhang, C., Moeller, A., West, G. M., Pascal, B. D., Van Eps, N., … Xu, H. E. (2015). Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser. Nature, 523(7562), 561–567. https://doi.org/10.1038/nature14656
   PubMed Web of Science ®Google Scholar
• Kim, K., & Chung, K. Y. (2020). Many faces of the GPCR-arrestin interaction. Archives of Pharmacol Research, 43(9), 890–899. https://doi.org/10.1007/s12272-020-01263-w
   PubMed Web of Science ®Google Scholar
• Kovoor, A., Celver, J., Abdryashitov, R. I., Chavkin, C., & Gurevich, V. V. (1999). Targeted construction of phosphorylation-independent beta-arrestin mutants with constitutive activity in cells. Journal of Biological Chemistry, 274(11), 6831–6834. https://doi.org/10.1074/jbc.274.11.6831
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A, Open Source Drug Discovery Consortium. (2014). g_mmpbsa – a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., Thompson, J. D., Gibson, T. J., & Higgins, D. G. (2007). Clustal W and Clustal X version 2.0. Bioinformatics (Oxford, England), 23(21), 2947–2948. https://doi.org/10.1093/bioinformatics/btm404
   PubMed Web of Science ®Google Scholar
• Latorraca, N. R., Masureel, M., Hollingsworth, S. A., Heydenreich, F. M., Suomivuori, C. M., Brinton, C., Townshend, R. J. L., Bouvier, M., Kobilka, B. K., & Dror, R. O. (2020). How GPCR phosphorylation patterns orchestrate arrestin-mediated signaling. Cell, 183(7), 1813–1825.e18. https://doi.org/10.1016/j.cell.2020.11.014
   PubMed Web of Science ®Google Scholar
• Latorraca, N. R., Wang, J. K., Bauer, B., Townshend, R. J. L., Hollingsworth, S. A., Olivieri, J. E., Xu, H. E., Sommer, M. E., & Dror, R. O. (2018). Molecular mechanism of GPCR-mediated arrestin activation. Nature, 557(7705), 452–456. https://doi.org/10.1038/s41586-018-0077-3
   PubMed Web of Science ®Google Scholar
• Lee, H., Whitfeld, P. L., & Mackay, C. R. (2008). Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2. Immunology and Cell Biology, 86(2), 153–160. https://doi.org/10.1038/sj.icb.7100166
   PubMed Web of Science ®Google Scholar
• Lee, Y., Choi, S., & Hyeon, C. (2014). Mapping the intramolecular signal transduction of G-protein coupled receptors. Proteins, 82(5), 727–743. https://doi.org/10.1002/prot.24451
   PubMed Web of Science ®Google Scholar
• Lee, Y., Warne, T., Nehme, R., Pandey, S., Dwivedi-Agnihotri, H., Chaturvedi, M., Edwards, P. C., Garcia-Nafria, J., Leslie, A. G. W., Shukla, A. K., & Tate, C. G. (2020). Molecular basis of beta-arrestin coupling to formoterol-bound beta(1)-adrenoceptor. Nature, 583(7818), 862–866. https://doi.org/10.1038/s41586-020-2419-1
   PubMed Web of Science ®Google Scholar
• Li, R., Coulthard, L. G., Wu, M. C., Taylor, S. M., & Woodruff, T. M. (2013). C5L2: A controversial receptor of complement anaphylatoxin, C5a. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 27(3), 855–864. https://doi.org/10.1096/fj.12-220509
   PubMed Web of Science ®Google Scholar
• Li, X. X., Lee, J. D., Kemper, C., & Woodruff, T. M. (2019). The complement receptor C5aR2: A powerful modulator of innate and adaptive immunity. Journal of Immunology (Baltimore, Md.: 1950), 202(12), 3339–3348. https://doi.org/10.4049/jimmunol.1900371
   PubMed Web of Science ®Google Scholar
• Luttrell, L. M., & Lefkowitz, R. J. (2002). The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. Journal of Cell Science, 115(Pt 3), 455–465. https://doi.org/10.1242/jcs.115.3.455
   PubMed Web of Science ®Google Scholar
• Mastellos, D., Andronis, C., Persidis, A., & Lambris, J. D. (2005). Novel biological networks modulated by complement. Clinical Immunology (Orlando, Fla.), 115(3), 225–235. https://doi.org/10.1016/j.clim.2005.03.012
   PubMed Web of Science ®Google Scholar
• Miller, W. E., & Lefkowitz, R. J. (2001). Expanding roles for β-arrestins as scaffolds and adapters in GPCR signaling and trafficking. Current Opinion in Cell Biology, 13(2), 139–145. https://doi.org/10.1016/S0955-0674(00)00190-3
   PubMed Web of Science ®Google Scholar
• Mishra, R., Behera, L. M., & Rana, S. (2022). Binding of raloxifene to human complement fragment 5a ((h)C5a): A perspective on cytokine storm and COVID19. Journal of Biomolecular Structure & Dynamics, 40(3), 982–994. https://doi.org/10.1080/07391102.2020.1820381
   PubMed Web of Science ®Google Scholar
• Mishra, R., Das, A., & Rana, S. (2021). Resveratrol binding to human complement fragment 5a ((h)C5a) may modulate the C5aR signaling axes. Journal of Biomolecular Structure & Dynamics, 39(5), 1766–1780. https://doi.org/10.1080/07391102.2020.1738958
   PubMed Web of Science ®Google Scholar
• Mishra, R., & Rana, S. (2019). A rational search for discovering potential neutraligands of human complement fragment 5a ((h)C5a). Bioorganic & Medicinal Chemistry, 27(19), 115052. https://doi.org/10.1016/j.bmc.2019.115052
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Nobles, K. N., Guan, Z., Xiao, K., Oas, T. G., & Lefkowitz, R. J. (2007). The active conformation of beta-arrestin1: Direct evidence for the phosphate sensor in the N-domain and conformational differences in the active states of beta-arrestins1 and -2. The Journal of Biological Chemistry, 282(29), 21370–21381. https://doi.org/10.1074/jbc.M611483200
   PubMed Web of Science ®Google Scholar
• Ohno, M., Hirata, T., Enomoto, M., Araki, T., Ishimaru, H., & Takahashi, T. A. (2000). A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. Molecular Immunology, 37(8), 407–412. https://doi.org/10.1016/S0161-5890(00)00067-5
   PubMed Web of Science ®Google Scholar
• Oldham, W. M., & Hamm, H. E. (2008). Heterotrimeric G protein activation by G-protein-coupled receptors. Nature Reviews. Molecular Cell Biology, 9(1), 60–71. https://doi.org/10.1038/nrm2299
   PubMed Web of Science ®Google Scholar
• Pandey, S., Kumari, P., Baidya, M., Kise, R., Cao, Y., Dwivedi-Agnihotri, H., Banerjee, R., Li, X. X., Cui, C. S., Lee, J. D., Kawakami, K., Maharana, J., Ranjan, A., Chaturvedi, M., Jhingan, G. D., Laporte, S. A., Woodruff, T. M., Inoue, A., & Shukla, A. K. (2021). Intrinsic bias at non-canonical, beta-arrestin-coupled seven transmembrane receptors. Molecular Cell, 81(22), 4605–4621.e11. https://doi.org/10.1016/j.molcel.2021.09.007
   PubMed Web of Science ®Google Scholar
• Park, J. Y., Qu, C. X., Li, R. R., Yang, F., Yu, X., Tian, Z. M., Shen, Y. M., Cai, B. Y., Yun, Y., Sun, J. P., & Chung, K. Y. (2019). Structural mechanism of the arrestin-3/JNK3 interaction. Structure (London, England: 1993), 27(7), 1162–1170.e3. https://doi.org/10.1016/j.str.2019.04.002
   PubMed Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera – A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• Pitcher, J. A., Freedman, N. J., & Lefkowitz, R. J. (1998). G protein-coupled receptor kinases. Annual Review of Biochemistry, 67, 653–692. https://doi.org/10.1146/annurev.biochem.67.1.653
   PubMed Web of Science ®Google Scholar
• Qu, L. H., Jin, X., Li, L. M., Li, S. Y., & Xie, H. P. (2014). A novel mutation in C5L2 gene was associated with hyperlipidemia and retinitis pigmentosa in a Chinese family. Lipids in Health and Disease, 13(1), 75. https://doi.org/10.1186/1476-511X-13-75
   PubMedGoogle Scholar
• Rana, S., & Sahoo, A. R. (2015). Model structures of inactive and peptide agonist bound C5aR: Insights into agonist binding, selectivity and activation. Biochemistry and Biophysics Reports, 1, 85–96. https://doi.org/10.1016/j.bbrep.2015.03.002
   PubMedGoogle Scholar
• Rana, S., Sahoo, A. R., & Majhi, B. K. (2016a). Allosterism in human complement component 5a ((h)C5a): A damper of C5a receptor (C5aR) signaling. Journal of Biomolecular Structure & Dynamics, 34(6), 1201–1213. https://doi.org/10.1080/07391102.2015.1073634
   PubMed Web of Science ®Google Scholar
• Rana, S., Sahoo, A. R., & Majhi, B. K. (2016b). Structural complexes of the agonist, inverse agonist and antagonist bound C5a receptor: Insights into pharmacology and signaling. Molecular bioSystems, 12(5), 1586–1599. https://doi.org/10.1039/c6mb00031b
   PubMedGoogle Scholar
• Rittirsch, D., Flierl, M. A., Nadeau, B. A., Day, D. E., Huber-Lang, M., Mackay, C. R., Zetoune, F. S., Gerard, N. P., Cianflone, K., Kohl, J., Gerard, C., Sarma, J. V., & Ward, P. A. (2008). Functional roles for C5a receptors in sepsis. Nature Medicine, 14(5), 551–557. https://doi.org/10.1038/nm1753
   PubMed Web of Science ®Google Scholar
• Rovati, G. E., Capra, V., & Neubig, R. R. (2007). The highly conserved DRY motif of class A G protein-coupled receptors: Beyond the ground state. Molecular Pharmacology, 71(4), 959–964. https://doi.org/10.1124/mol.106.029470
   PubMed Web of Science ®Google Scholar
• Sahoo, A. R., Mishra, R., & Rana, S. (2018). The model structures of the complement component 5a receptor (C5aR) bound to the native and engineered (h)C5a. Scientific Reports, 8(1), 2955. https://doi.org/10.1038/s41598-018-21290-4
   PubMed Web of Science ®Google Scholar
• Scheerer, P., & Sommer, M. E. (2017). Structural mechanism of arrestin activation. Current Opinion in Structural Biology, 45, 160–169. https://doi.org/10.1016/j.sbi.2017.05.001
   PubMed Web of Science ®Google Scholar
• Scola, A. M., Johswich, K. O., Morgan, B. P., Klos, A., & Monk, P. N. (2009). The human complement fragment receptor, C5L2, is a recycling decoy receptor. Molecular Immunology, 46(6), 1149–1162. https://doi.org/10.1016/j.molimm.2008.11.001
   PubMed Web of Science ®Google Scholar
• Seyedabadi, M., Gharghabi, M., Gurevich, E. V., & Gurevich, V. V. (2021). Receptor-arrestin interactions: The GPCR perspective. Biomolecules, 11(2), 218. https://doi.org/10.3390/biom11020218
   Google Scholar
• Shi, L., Liapakis, G., Xu, R., Guarnieri, F., Ballesteros, J. A., & Javitch, J. A. (2002). Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. Journal of Biological Chemistry, 277(43), 40989–40996. https://doi.org/10.1074/jbc.M206801200
   PubMed Web of Science ®Google Scholar
• Shukla, A. K., Manglik, A., Kruse, A. C., Xiao, K., Reis, R. I., Tseng, W. C., Staus, D. P., Hilger, D., Uysal, S., Huang, L. Y., Paduch, M., Tripathi-Shukla, P., Koide, A., Koide, S., Weis, W. I., Kossiakoff, A. A., Kobilka, B. K., & Lefkowitz, R. J. (2013). Structure of active beta-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide. Nature, 497(7447), 137–141. https://doi.org/10.1038/nature12120
   PubMed Web of Science ®Google Scholar
• Shukla, A. K., Xiao, K., & Lefkowitz, R. J. (2011). Emerging paradigms of beta-arrestin-dependent seven transmembrane receptor signaling. Trends in Biochemical Sciences, 36(9), 457–469. https://doi.org/10.1016/j.tibs.2011.06.003
   PubMed Web of Science ®Google Scholar
• Smith, J. S., & Rajagopal, S. (2016). The β-arrestins: Multifunctional regulators of G protein-coupled receptors. Journal of Biological Chemistry, 291(17), 8969–8977. https://doi.org/10.1074/jbc.R115.713313
   PubMed Web of Science ®Google Scholar
• Song, X., Coffa, S., Fu, H., & Gurevich, V. V. (2009). How does arrestin assemble MAPKs into a signaling complex? Journal of Biological Chemistry, 284(1), 685–695. https://doi.org/10.1074/jbc.M806124200
   PubMed Web of Science ®Google Scholar
• Staus, D. P., Hu, H., Robertson, M. J., Kleinhenz, A. L. W., Wingler, L. M., Capel, W. D., Latorraca, N. R., Lefkowitz, R. J., & Skiniotis, G. (2020). Structure of the M2 muscarinic receptor-beta-arrestin complex in a lipid nanodisc. Nature, 579(7798), 297–302. https://doi.org/10.1038/s41586-020-1954-0
   PubMed Web of Science ®Google Scholar
• Sutton, R. B., Vishnivetskiy, S. A., Robert, J., Hanson, S. M., Raman, D., Knox, B. E., Kono, M., Navarro, J., & Gurevich, V. V. (2005). Crystal structure of cone arrestin at 2.3A: Evolution of receptor specificity. Journal of Molecular Biology, 354(5), 1069–1080. https://doi.org/10.1016/j.jmb.2005.10.023
   PubMed Web of Science ®Google Scholar
• Trzaskowski, B., Latek, D., Yuan, S., Ghoshdastider, U., Debinski, A., & Filipek, S. (2012). Action of molecular switches in GPCRs – Theoretical and experimental studies. Current Medicinal Chemistry, 19(8), 1090–1109. https://doi.org/10.2174/092986712799320556
   PubMed Web of Science ®Google Scholar
• van Gastel, J., Hendrickx, J. O., Leysen, H., Santos-Otte, P., Luttrell, L. M., Martin, B., & Maudsley, S. (2018). Beta-arrestin based receptor signaling paradigms: Potential therapeutic targets for complex age-related disorders. Frontiers in Pharmacology, 9, 1369. https://doi.org/10.3389/fphar.2018.01369
   PubMed Web of Science ®Google Scholar
• Van Lith, L. H., Oosterom, J., Van Elsas, A., & Zaman, G. J. (2009). C5a-stimulated recruitment of beta-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2. Journal of Biomolecular Screening, 14(9), 1067–1075. https://doi.org/10.1177/1087057109341407
   PubMedGoogle Scholar
• VanPatten, S., & Al-Abed, Y. (2018). High mobility group box-1 (HMGb1): Current wisdom and advancement as a potential drug target. Journal of Medicinal Chemistry, 61(12), 5093–5107. https://doi.org/10.1021/acs.jmedchem.7b01136
   PubMed Web of Science ®Google Scholar
• Vijayan, S., Asare, Y., Grommes, J., Soehnlein, O., Lutgens, E., Shagdarsuren, G., Togtokh, A., Jacobs, M. J., Fischer, J. W., Bernhagen, J., Weber, C., Schober, A., & Shagdarsuren, E. (2014). High expression of C5L2 correlates with high proinflammatory cytokine expression in advanced human atherosclerotic plaques. American Journal of Pathology, 184(7), 2123–2133. https://doi.org/10.1016/j.ajpath.2014.04.004
   PubMed Web of Science ®Google Scholar
• Vishnivetskiy, S. A., Huh, E. K., Gurevich, E. V., & Gurevich, V. V. (2021). The finger loop as an activation sensor in arrestin. Journal of Neurochemistry, 157(4), 1138–1152. https://doi.org/10.1111/jnc.15232
   PubMed Web of Science ®Google Scholar
• Wingler, L. M., & Lefkowitz, R. J. (2020). Conformational basis of G protein-coupled receptor signaling versatility. Trends in Cell Biology, 30(9), 736–747. https://doi.org/10.1016/j.tcb.2020.06.002
   PubMed Web of Science ®Google Scholar
• Xue, L. C., Rodrigues, J. P., Kastritis, P. L., Bonvin, A. M., & Vangone, A. (2016). PRODIGY: A web server for predicting the binding affinity of protein-protein complexes. Bioinformatics (Oxford, England), 32(23), 3676–3678. https://doi.org/10.1093/bioinformatics/btw514
   PubMed Web of Science ®Google Scholar
• Yang, F., Yu, X., Liu, C., Qu, C. X., Gong, Z., Liu, H. D., Li, F. H., Wang, H. M., He, D. F., Yi, F., Song, C., Tian, C. L., Xiao, K. H., Wang, J. Y., & Sun, J. P. (2015). Phospho-selective mechanisms of arrestin conformations and functions revealed by unnatural amino acid incorporation and (19)F-NMR. Nature Communications, 6, 8202. https://doi.org/10.1038/ncomms9202
   PubMed Web of Science ®Google Scholar
• Zhan, X., Gimenez, L. E., Gurevich, V. V., & Spiller, B. W. (2011). Crystal structure of arrestin-3 reveals the basis of the difference in receptor binding between two non-visual subtypes. Journal of Molecular Biology, 406(3), 467–478. https://doi.org/10.1016/j.jmb.2010.12.034
   PubMed Web of Science ®Google Scholar
• Zhang, T., Garstka, M. A., & Li, K. (2017). The controversial C5a receptor C5aR2: Its role in health and disease. Journal of Immunology Research, 2017, 8193932. https://doi.org/10.1155/2017/8193932
   PubMed Web of Science ®Google Scholar
• Zhang, T., Wu, K. Y., Ma, N., Wei, L. L., Garstka, M., Zhou, W., & Li, K. (2020). The C5a/C5aR2 axis promotes renal inflammation and tissue damage. JCI Insight, 5(7), e134081. https://doi.org/10.1172/jci.insight.134081
   Google Scholar
• Zheng, C., Tholen, J., & Gurevich, V. V. (2019). Critical role of the finger loop in arrestin binding to the receptors. PloS One, 14(3), e0213792. https://doi.org/10.1371/journal.pone.0213792
   PubMed Web of Science ®Google Scholar
• Zheng, Y. Y., Xie, X., Ma, Y. T., Yang, Y. N., Fu, Z. Y., Li, X. M., Ma, X., Chen, B. D., & Liu, F. (2013). A novel polymorphism (901G > a) of C5L2 gene is associated with coronary artery disease in Chinese Han and Uyghur population. Lipids in Health and Disease, 12(1), 139. https://doi.org/10.1186/1476-511X-12-139
   PubMedGoogle Scholar
• Zhou, X. E., Gao, X., Barty, A., Kang, Y., He, Y., Liu, W., Ishchenko, A., White, T. A., Yefanov, O., Han, G. W., Xu, Q., de Waal, P. W., Suino-Powell, K. M., Boutet, S., Williams, G. J., Wang, M., Li, D., Caffrey, M., Chapman, H. N., … Xu, H. E. (2016). X-ray laser diffraction for structure determination of the rhodopsin-arrestin complex. Scientific Data, 3, 160021. https://doi.org/10.1038/sdata.2016.21
   PubMed Web of Science ®Google Scholar
• Zhou, X. E., He, Y., de Waal, P. W., Gao, X., Kang, Y., Van Eps, N., Yin, Y., Pal, K., Goswami, D., White, T. A., Barty, A., Latorraca, N. R., Chapman, H. N., Hubbell, W. L., Dror, R. O., Stevens, R. C., Cherezov, V., Gurevich, V. V., Griffin, P. R., … Xu, H. E. (2017). Identification of phosphorylation codes for arrestin recruitment by G protein-coupled receptors. Cell, 170(3), 457–469.e13. https://doi.org/10.1016/j.cell.2017.07.002
   PubMed Web of Science ®Google Scholar